| Male | Female | |||
---|---|---|---|---|---|
β (95% CI) | P value | β (95% CI) | P value | ||
Model 1 | |||||
 TG (mmol/l) | 0.012 (-0.023–0.047) | 0.492 | -0.021 (-0.054–0.013) | 0.220 | |
 TC (mmol/l) | -0.036 (-0.067–-0.004) | 0.026* | -0.022 (-0.045–0.002) | 0.070 | |
 ApoA1(g/l) | 0.039 (-0.134–0.212) | 0.654 | -0.108 (-0.203–-0.014) | 0.025* | |
 ApoB (g/l) | -0.145 (-0.276–-0.014) | 0.030* | -0.082 (-0.185–0.022) | 0.122 | |
 ApoA1/ApoB | 0.086 (0.007–0.165) | 0.034* | -0.006 (-0.054–0.041) | 0.798 | |
 HDL-C (mmol/l) | -0.008 (-0.174–0.159) | 0.929 | -0.064 (-0.163–-0.035) | 0.201 | |
 LDL-C (mmol/L) | -0.054 (-0.100–-0.009) | 0.020* | -0.015 (-0.050–0.020) | 0.406 | |
 FFA (mmol/l) | -0.287 (-0.464–-0.110) | 0.002* | -0.290 (-0.412–-0.167) | <0.001* | |
 IL-6 (pg/ml) | -0.007 (-0.011–-0.004) | <0.001* | -0.007 (-0.010–-0.005) | <0.001* | |
Model 2 | |||||
 TG (mmol/l) | 0.012 (-0.023–0.048) | 0.493 | -0.016 (-0.045–0.012) | 0.254 | |
 TC (mmol/l) | -0.037 (-0.069–-0.005) | 0.024* | -0.032 (-0.052–-0.012) | 0.002* | |
ApoA1(g/l) | 0.039 (-0.134–0.213) | 0.655 | -0.105 (-0.184–-0.025) | 0.011* | |
 ApoB (g/l) | -0.150 (-0.283–-0.017) | 0.028* | -0.134 (-0.221–-0.047) | 0.003* | |
 ApoA1/ApoB | 0.090 (0.009–0.171) | 0.030* | 0.020 (-0.021–0.061) | 0.334 | |
 HDL-C (mmol/l) | -0.007 (-0.176–0.161) | 0.930 | -0.073 (-0.157–0.011) | 0.087 | |
 LDL-C (mmol/l) | -0.057 (-0.104–-0.010) | 0.017* | -0.033 (-0.063–-0.003) | 0.029* | |
 FFA (mmol/l) | -0.293 (-0.473–-0.113) | 0.002* | -0.158 (-0.272–-0.044) | 0.007* | |
 IL-6 (pg/ml) | -0.008 (-0.012–-0.004) | <0.001* | -0.003 (-0.006–0.000) | 0.061 |